TBPMF News and Press, Tetra Bio-Pharma Inc From 07/27/20

OTTAWA, CANADA / ACCESSWIRE / July 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP ) (OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is providing its shareholders with a management update on the Company's Annual General Meeting (AGM) o...

FDA stated that the nonclinical program was appropriate to support initiating studies in COVID-19 patients OTTAWA, CANADA / ACCESSWIRE / July 16, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and devel...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, ON / ACCESSWIRE / July 15, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP ) (OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleas...

OTTAWA / ACCESSWIRE / July 9, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has appointed Steve Edgett as a Strategic Advisor. Mr. Edgett will act as a specia...

OTTAWA / ACCESSWIRE / June 25, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP ) (OTCQB: TBPMF ), a leader in drug discovery and development for cannabinoid-based therapeutics, is pleased to announce the grant of an aggregate of 1,535,583 stock options (each, an "Option") ...

Phoenix, Arizona--(Newsfile Corp. - June 22, 2020) - The Stock Day Podcast welcomed Tetra Bio-Pharma (TSXV: TBP) (OTCQB: TBPMF) ("the Company") , a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed and approved, clinic...

Change represents evolving board capabilities as Tetra enters next stage of its corporate development OTTAWA, ON / ACCESSWIRE / June 22, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a bio-pharmaceutical company engaged in cannabinoid-derived drug ...

OTTAWA, ON / ACCESSWIRE / June 17, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, today provides an update on the development of its ARDS-003 intravenous drug pr...

Resumption of its PLENITUDE © clinical trial to bring QIXLEEF™ to market ReBorn © clinical trial to resume to bring CAUMZ™ to the market as an alternative to opioids for breakthrough pain QIXLEEF™ metabolite mapping ongoing OTTAWA, ON / ACCESS...

OTTAWA, ON / ACCESSWIRE / June 4, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP )(OTCQB: TBPMF ), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development and Storz & Bickel, a subsidiary of Canopy Growth Corporation, (TSX: WEED )(...